Skip to main content

Table 2 Factors associated with rifampin-resistant Mycobacterium tuberculosis based on Xpert MTB/RIF assay

From: Rifampin resistance and diabetes mellitus in a cross-sectional study of adult patients in rural South India

 

Rifampin resistance

 

Univariate

Multivariate

 

RR (95 % CI)

P

aRR (95 % CI)

P

Age (years)

0.99 (0.96–1.03)

0.78

---

---

Sex (male)

0.58 (0.18–1.88)

0.37

---

---

Diabetesa

3.11 (1.35–7.17)

<0.01

2.96 (1.30–6.74)

<0.01

Previous TB Treatment

3.52 (1.58–7.84)

<0.01

3.33 (1.53–7.22)

<0.01

BCG Vaccination

0.60 (0.26–1.36)

0.22

---

---

TB Symptoms (weeks)b

1.00 (0.97–1.03)

0.81

---

---

QFT-G

2.02 (0.50–8.22)

0.33

---

---

AFB

3.60 (0.87–14.91)

0.08

3.14 (1.03–9.58)

0.05

  1. Abbreviations: AFB Acid-fast bacilli sputum smear microscopy, BCG Bacille Calmette-Guérin, CI confidence interval, TB tuberculosis, QFT-G Quantiferon-TB Gold In-Tube, RR risk ratio, aRR adjusted risk ratio
  2. aAccording to patient self-report
  3. bTime (weeks) since initial onset of symptoms suggestive of TB, including persistent cough, fever, weight loss